The safety and efficacy of DAXXIFY is well established, with more than 20 years of research. In fact, DAXXIFY has been studied in the largest ever phase 3 clinical trial program conducted for a frown line treatment and included more than 2,400 people across different ages and with different skin types. There were no notable differences in how DAXXIFY performed in clinical trial patients with varying skin types.